First Header Logo Second Header Logo

Connection

Kathryn Weaver to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Kathryn Weaver has written about Drug Administration Schedule.
Kathryn Weaver
Connection Strength
0.027
Drug Administration Schedule
  1. Petty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, Weaver KE, Miller AA. Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer. Int J Oncol. 2013 Dec; 43(6):2057-63.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.